Auris Medical Holding Ltd Share Price Nasdaq
Equities
BMG070251027
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 2.64M 2.95M 246M |
---|---|---|---|---|---|
Net income 2024 * | -7M -7.83M -653M | Net income 2025 * | -10M -11.18M -933M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.3
x | P/E ratio 2025 * |
-0.41
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.11% |
Latest transcript on Auris Medical Holding Ltd
Managers | Title | Age | Since |
---|---|---|---|
Thomas Meyer
CEO | Chief Executive Officer | 56 | 01/03/01 |
Marcel Gremaud
DFI | Director of Finance/CFO | 66 | 01/21/01 |
Covadonga Pañeda
COO | Chief Operating Officer | 51 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Alain Munoz
BRD | Director/Board Member | 75 | 01/18/01 |
Mats Blom
BRD | Director/Board Member | 59 | 01/17/01 |
Thomas Meyer
CEO | Chief Executive Officer | 56 | 01/03/01 |
1st Jan change | Capi. | |
---|---|---|
+16.85% | 124B | |
+16.69% | 109B | |
-7.22% | 23.84B | |
+1.98% | 22.42B | |
-14.29% | 17.5B | |
-7.24% | 16.61B | |
-37.63% | 16.43B | |
+2.31% | 13.4B | |
+24.26% | 11.47B |